Letters to the Editor
Vol. 13 No. 1 (2021): Mediterranean Journal of Hematology and Infectious Diseases, Volume 13, 2021
https://doi.org/10.4084/MJHID.2021.048

A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2

Ophthalmic vein thrombosis following Covid

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: June 28, 2021
1613
Views
428
Downloads
377
HTML
COVID, Ophthalmic vein thrombosis, thrombocytopenia

Authors

Irina Panovska-Stavridis
dr_irina@yahoo.com
a:1:{s:5:"en_US";s:38:"University Clinic of hematology-Skopje";}, North Macedonia.

x

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
WHO. WHO target product profiles for COVID-19 vaccines April 9, 2020. https://www.who.int/publications/m/item/whotarget-product-profiles-for-covid-19-vaccines (accessed, Maj 5, 2021).
Voysey M, Clemens SAC, Madhi SA, et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 2021 J; 397(10269):99-111. doi: 10.1016/S0140-6736(20)32661-1.
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle PA, Eichinger S. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination. N Engl J Med. 2021 Apr 9; NEJMoa2104840. doi: 10.1056/NEJMoa2104840
Pai M, Chan B, Stall NM, et al. Vaccine-induced immune thrombotic thrombocytopenia (VITT) following adenovirus vector COVID-19 vaccination. Science Briefs of the Ontario COVID-19 Science Advisory Table. 2021;2(17):1-7. https://doi.org/10.47326/ ocsat.2021.02.17.2.0
Bayas A, Menacher M2, Christ M, et al. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination
Lancet 2021 May 1; 397(10285):e11. doi: 10.1016/S0140-6736(21)00872-2.
Strobel E. Use of the ID-PaGIA Heparin/PF4 Antibody Test as a screening test for heparin/platelet factor 4 antibodies. Blood Transfus. 2017;15(3):268-271. doi:10.2450/2016.0302-15
https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood (accessed, Maj 5, 2021)
https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/janssen-covid-19-vaccine (accessed, Maj 5, 2021)

How to Cite



“A rare case of superior ophthalmic vein thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: Ophthalmic vein thrombosis following Covid” (2021) Mediterranean Journal of Hematology and Infectious Diseases, 13(1), p. e2021048. doi:10.4084/MJHID.2021.048.
Copyright (c) 2021 Irina Panovska-Stavridis Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.